We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9147:TSENippon Express Holdings, Inc. Analysis

Data as of 2026-08-19 - not real-time

¥5,516.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

The moving-average structure behind Nippon Express Holdings, Inc. is bullish at ¥5,516.00, with short-term averages leading the long-term ones. Momentum indicators put RSI at 54.7 (neutral) with MACD reading bullish. Price has been bracketed by support at ¥5,037.00 and resistance at ¥5,793.00.
The shares look overvalued, trading on 70.9 times earnings above a sector average of 30.2. The average analyst target implies 9.8% below today's level. Revenue is growing at 12.4% on a 0.7% profit margin. The 1.77% dividend yield looks stretched against payout coverage.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 33.1%, a beta of 0.25 and a maximum drawdown of 9.3%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 1 out of 10.

Top Market Events

Elliott Investment Management has publicly challenged Nippon Express Holdings TSE:9147 to pause its M&A plans, focus on...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 4129.97
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 70.9 versus sector average of 30.2
  • Dividend yield of 1.77% looks stretched against payout coverage

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 70.9 versus sector average of 30.2
  • Dividend yield of 1.77% looks stretched against payout coverage
  • Analyst targets imply -9.8% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth12.40%
Profit Margin0.70%
P/E Ratio70.9
ROE2.46%
ROA0.02%
Debt/Equity101.72
P/B Ratio1.6
Op. Cash Flow¥196.2B
Free Cash Flow¥71.0B
Industry P/E30.2

Technical Analysis

TrendBullish
RSI54.7
Support¥5,037.00
Resistance¥5,793.00
MA 20¥5,419.25
MA 50¥5,306.82
MA 200¥4,129.97
MACDBullish
VolumeIncreasing
Fear & Greed Index94.84

Valuation

Fair Value¥3,676.79
Target Price¥4,977.50
Upside/Downside-9.76%
GradeOvervalued
TypeBlend
Dividend Yield1.77%

Risk Assessment

Beta0.25
Volatility33.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.